Follow The Filings

NOVT Novanta Inc.

Information Technology, filed as NOVANTA INC (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 3 managers in 2026 Q2, sold by 1

  • 1 Owner
  • Max 0.3%
  • $2M
  • 1 add

In 2026 Q3 Torray Investment Partners added to Novanta.

Who owns this now

Largest portfolio weights among holders, up to 0.3% (Torray Investment Partners). Not free-float ownership.

  1. Torray Investment Partners Add 0.26%

Who owns NOVT

Sorted by value, long equity only, as of 2026 Q3.

History
Torray Investment Partners 0.26%, was 0.25% Add +23.2% 13,731 $2M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by NOVT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All NOVT insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $11.6M sold by 3 insiders under 10b5-1 plans
  1. Thomas N Secor Director
    Planned sale
    $98K 663 shares at $147.60 50% of stake
    Traded Sep 11 Filed Sep 15
    ↗
  2. Matthijs Glastra CEO
    Planned sale
    $1M 6,500 shares at $161.13 18% of stake
    Traded Jul 2 Filed Jul 7
    ↗
  3. Matthijs Glastra CEO
    Planned sale
    $1.1M 6,500 shares at $168.66 15% of stake
    Traded Jun 2 Filed Jun 4
    ↗
  4. Matthijs Glastra CEO
    Planned sale
    $1.1M 7,500 shares at $150.43 15% of stake
    Traded May 12 Filed May 14
    ↗
  5. Matthijs Glastra CEO
    Planned sale
    $852K 6,500 shares at $131.13 12% of stake
    Traded May 5 Filed May 7
    ↗
  6. Matthijs Glastra CEO
    Planned sale
    $845K 6,500 shares at $130.05 10% of stake
    Traded Apr 17 Filed Apr 21
    ↗
  7. Robert Buckley CFO
    Planned sale
    $1.2M 9,957 shares at $116.77 9.3% of stake
    Traded Mar 16 Filed Mar 18
    ↗
  8. Matthijs Glastra CEO
    Planned sale
    $899K 6,500 shares at $138.34 9.3% of stake
    Traded Mar 2 Filed Mar 4
    ↗
  9. Robert Buckley CFO
    Planned sale
    $200K 1,423 shares at $140.88 1.5% of stake
    Traded Feb 20 Filed Feb 24
    ↗
  10. Matthijs Glastra CEO
    Planned sale
    $1.1M 7,500 shares at $145.04 12% of stake
    Traded Feb 10 Filed Feb 12
    ↗
  11. Matthijs Glastra CEO
    Planned sale
    $878K 6,500 shares at $135.15 9.1% of stake
    Traded Feb 2 Filed Feb 4
    ↗
  12. Robert Buckley CFO
    Planned sale
    $199K 1,423 shares at $140.14 1.5% of stake
    Traded Jan 21 Filed Jan 23
    ↗
  13. Matthijs Glastra CEO
    Planned sale
    $1M 7,500 shares at $140.00 9.5% of stake
    Traded Jan 21 Filed Jan 23
    ↗
  14. Matthijs Glastra CEO
    Planned sale
    $803K 6,177 shares at $130.00 7.3% of stake
    Traded Jan 9 Filed Jan 13
    ↗
  15. Matthijs Glastra CEO
    Planned sale
    $42K 323 shares at $130.14 0.4% of stake
    Traded Jan 8 Filed Jan 12
    ↗

Also filed in the last 12 months, not counted as buying or selling: 25 option exercises, 15 share withholdings for taxes, and 2 gifts.

Congress

2 members of Congress traded NOVT in the last three years: 3 buys and 1 sale. 2 members listed it in 2025 annual reports.

All Congress trades
  1. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K May 18 filed Jun 8
  2. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Nov 13, 2025 filed Dec 15, 2025
  3. Lisa C. McClain R-MI-9Spouse Sell $1K–$15K Aug 4, 2025 filed Sep 12, 2025
  4. Lisa C. McClain R-MI-9Spouse Buy $1K–$15K Jul 22, 2025 filed Aug 13, 2025

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
8-K/A 9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.01,2.03,7.01,9.01 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
8-K 1.01,3.02,8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
DEF 14A Filing Doc
SCHEDULE 13G/A — Filing Doc
10-K Filing Doc

Source: SEC EDGAR submissions, updated 13 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $881.66M $949.24M $980.6M
Gross profit $399.9M $421.54M $435.28M
Gross margin * 45.4% 44.4% 44.4%
Net income $72.88M $64.09M $53.83M
Net margin * 8.3% 6.8% 5.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $415.3M $433.65M $782.6M
Total non-current assets * $0.811B $0.955B $1.02B
Total assets $1.23B $1.39B $1.81B
Total current liabilities $139.18M $167.79M $212.37M
Total non-current liabilities * $413.42M $475.02M $280.45M
Total equity $0.673B $0.746B $1.31B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $120.08M $158.51M $64.06M
Cash from investing -$19.89M -$208.19M -$74.32M
Cash from financing -$97.85M $56.94M $276.33M
Net change in cash $4.95M $8.94M $266.88M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.